Jörn Schattenberg and Louise Campbell discuss their excitement about NASH Community Collaboration around issues ranging from clinical trial design to care pathways to the role of patients.
The SurfingNASH team (Jörn Schattenberg, Louise Campbell, Roger Green) join Global Liver Institute NASH Programs Director Jeff McIntyre for the wrap-up panel of #NASHDay 2022.
The Big Band (Stephen Harrison, Jörn Schattenberg, Louise Campbell, Roger Green) convenes on the eve of #NASHDay 2022 to ask what has changed in the Fatty Liver world in the last twelve months and to recognize the powerful impact of patient advocacy.
Quentin Anstee joins the Surfers (including Stephen Harrison) to share lessons about the proper use of non-invasive tests in the clinical trial process and to explore implications for best practices and future research or research.
As Jörn Schattenberg joins the permanent Surfing crew, he sits with Louise Campbell and Roger Green to share his background and focus and to discuss where SurfingNASH.com will take NASH Tsunami in its third full year.
NAIL-NIT co-leads Stephen Harrison and Mazen Noureddin describe the conversation that stimulated them to develop NAIL-NIT and why they are so committed to moving NAFLD diagnostics Beyond the Biopsy.
News about a new company to steer Surfing the NASH Tsunami into the future plus new roles for Stephen Harrison and Jörn Schattenberg
NAIL-NIT co-leads Stephen Harrison and Mazen Noureddin and retrospective analysis co-leads Naim Alkhouri and Jörn Schattenberg join Louise and Roger to discuss designs and plans for NAIL-NIT retrospective analysis.
Work flows for NAIL-NIT: Retrospective analysis planning to produce results in 1-2 years, then prospective studies planning to produce results in 4-6 years.
How can data from NAIL-NIT address the challenges of the NAS score and provide more robust data to diagnose and treat individual patients with the optimal therapy?
